181 results
Page 8 of 10
6-K
EX-99.1
ga0zynqlngn3t5
23 Oct 18
Positive Trial Results with Filgotinib In Psoriatic Arthritis and Ankylosing Spondylitis Both Published In the Lancet
7:59am
6-K
EX-99.1
z3gouxh
22 Oct 18
Phase 3 Data on Filgotinib In Biologic-experienced Rheumatoid Arthritis to Be Presented at 2018 Acr/arhp Annual Meeting
6:05am
6-K
EX-99.1
cw6y3k xkq
24 Sep 18
Galapagos reports initiation of global ROCCELLA Phase 2 clinical trial with GLPG1972/S201086 in osteoarthritis patients
6:05am
424B5
6tm66
13 Sep 18
Prospectus supplement for primary offering
12:00am
6-K
EX-99.1
2orqj
13 Sep 18
Galapagos raises $300 million gross proceeds in a U.S. public offering
12:00am
6-K
EX-99.1
63jy2jnxj5ha7vp1
13 Sep 18
MorphoSys and Galapagos announce U.S. Antitrust Clearance for global license agreement for MOR106 with pharma partner
12:00am
6-K
EX-99.1
lah0drqpl5
13 Sep 18
Galapagos announces launch of proposed public offering
12:00am
6-K
EX-99.1
lsuq qchw9ej6
11 Sep 18
Gilead and Galapagos Announce Filgotinib Meets Primary and All Key Secondary Endpoints In First Phase 3 Study In Rheumatoid Arthritis
12:00am
6-K
EX-99.1
62hya1tl
2 Aug 18
Current report (foreign)
4:03pm
6-K
EX-99.2
6p10 nwk5b91
2 Aug 18
Current report (foreign)
4:03pm
6-K
EX-99.1
7bh7e9cq08o
19 Jul 18
Current report (foreign)
6:05am
6-K
EX-99.1
u3p1qm 4kc7d3nj
9 Jul 18
Galapagos announces design for PINTA Phase 2 trial with GLPG1205 in IPF
6:10am
6-K
EX-99.1
oz50z65o0d8j1625hp2
29 Jun 18
Topline results of PELICAN trial and update on triple combo development plans
12:00am
6-K
EX-99.1
l81dwtgc1
27 Jun 18
Servier and Galapagos announce start of global ROCCELLA Phase 2 clinical trial with S201086/GLPG1972 in osteoarthritis patients
6:01am
6-K
EX-99.1
lepmoewufqhmhzg
5 Jun 18
Current report (foreign)
12:00am
6-K
EX-99.1
k54wsjjoek
22 May 18
GLPG1690 results in IPF published in The Lancet Respiratory Medicine and presented at ATS
6:00am
6-K
EX-99.1
wease5a27xrlb8nl
2 May 18
Galapagos and MorphoSys announce initiation of the IGUANA Phase 2 clinical trial with MOR106 in atopic dermatitis patients
6:00am
6-K
EX-99.1
qjy0kw lmfj51dx
1 May 18
Galapagos presents strong disease-modifying effects in preclinical model of osteoarthritis with GLPG1972 at OARSI 2018
8:26am
6-K
EX-99.2
5agfhhwm7r5nmfpejjv9
27 Apr 18
Galapagos reports first quarter 2018 results
12:00am
6-K
EX-99.1
wxd42 8q8
27 Apr 18
Galapagos reports first quarter 2018 results
12:00am